This analysis reveals a link between topical corticosteroid use and cataract risk in patients with uveitis, suggesting caution during inactive disease periods.
Topical CS use is associated with higher cataract risk during inactive or borderline disease activity periods, but not during clearcut disease activity periods (during which anti-inflammatory effects may be beneficial).
No takes yet. Share an insight, caveat, or question.
Rosner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: